Exosome Biomarker Profiling Using a Paper-Based Vertical Flow Assay.

Area of Science:

• Biotechnology
• Nanotechnology
• Cancer Research

Background:

• Exosomes are nanoscale extracellular vesicles crucial for intercellular communication and disease biomarker discovery.
• Current exosome characterization methods, like flow cytometry, are often complex, costly, and time-consuming.
• There is a need for simplified, accessible techniques for exosome detection and profiling, particularly in cancer research.

Purpose of the Study:

• To develop and validate a paper-based Vertical Flow Assay (VFA) for detecting and profiling exosomes from metastatic breast cancer cell lines.
• To establish the VFA as a low-cost, rapid, and reliable alternative to traditional exosome analysis methods.
• To demonstrate the VFA's capability for quantifying exosomal surface proteins.

Main Methods:

• The VFA utilizes an ELISA-like format with specific antibodies targeting exosomal surface proteins (CD9, CD63, CD81, EGFR1).
• A secondary antibody conjugated to alkaline phosphatase generates a visual signal upon substrate reaction, visualized on a nitrocellulose membrane.
• Smartphone imaging was employed for signal quantification, and assay parameters were optimized for performance.

Main Results:

• The optimized VFA achieved a detection limit of approximately 6 × 10⁷ exosomes µL^-1 in under 20 minutes.
• Comparative analysis with bead-based flow cytometry confirmed consistent biomarker expression profiles, validating the VFA's reliability.
• The assay successfully detected and profiled key exosomal markers relevant to metastatic breast cancer.

Conclusions:

• The paper-based VFA offers a simplified, low-cost, and rapid method for exosome detection and biomarker profiling.
• This assay presents a promising alternative to flow cytometry for exosome characterization in various research and diagnostic applications.
• The VFA technology has the potential to broaden accessibility to exosome analysis in cancer research and beyond.